Skip to main content
Equibles
EVGN logo

EVGN · Evogene Ltd.

Track EVGN — free

Use EVGN with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$0.54 +0.02 (+3.57%)
Rebalance outlook locked
Market Cap
$8.22M
Shares
15.80M

Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Past events

Date Event Type
2026-08-18 Earnings conference call (announced in 6-K) Earnings call
2026-06-22 BIO International Convention 2026 Event
2026-05-19 24th Schrödinger European User Group Meeting Event
2026-03-23 BIO-Europe Spring 2026 Event
2025-11-03 BIO-Europe 2025 Event
2025-09-09 Evogene to Present at H.C. Wainwright 27th Annual Global Investment Conference in New York Conference
2025-06-16 BIO 2025 Boston Event
2025-05-25 AI x FoodTech Event
2025-05-20 Biomed Israel 2025 Event
2025-03-17 BioEurope Spring Event
2024-11-04 Dr. Ruth Gross, Evogene’s VP of Business Development for Pharma, to attend BIO-Europe 2024 Event
2024-11-04 BIO-Europe 2024 Event
2024-10-20 HLTH 2024 Las Vegas, USA Event
2024-10-20 Dr. Ruth Gross, Evogene’s VP of Business Development for Pharma, to attend HLTH 2024 in Las Vegas Event
2024-07-24 BIO Asia-Taiwan 2024 Event
2024-06-06 2024 Annual General Meeting of Shareholders Shareholder meeting
2024-06-03 Dr. Ruth Gross, Evogene’s VP of Business Development for Pharma, to attend BIO International Convention 2024 Event
2024-06-03 BIO International Convention 2024 Event
2024-05-31 Biomica to Present at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting Shareholder meeting
2024-05-23 Evogene First Quarter 2024 Financial Results, May 23, 2024 Event
2024-05-21 Eyal Ronen, Evogene EVP of Business Development, to attend Blue Food Innovation Summit, London Event
2024-05-21 Dr. Ruth Gross, Evogene’s VP Business Development Pharma, to attend Biomed Israel 2024 Event
2024-03-28 CISH Impact Investments Conference (Virtual) Conference
2024-03-19 World Agri-Tech Innovation Summit 2024 Event
2024-03-12 Biomica’s VP R&D, Dr. Shiri Meshner, to present at Pharmabiotic Conference 2024 Conference
Key facts CIK 1574565 CUSIP M4119S187 13F (30d) 19 filings 16 filers Visit website

Report a Problem

Category
Description
Email (optional, for follow-up)